Skip to Main Content


Skip Nav Destination

Augmentation of the anti-tumor therapeutic efficacy of long-term cultured T lymphocytes by in vivo administration of purified interleukin 2.

J Exp Med (1982) 155 (4): 968–980.
Currently there are no citedby results. Try again later.
Close Modal

or Create an Account

Close Modal
Close Modal